TGA Approval

TYSABRI natalizumab 150 mg/1 mL injection solution pre-filled syringe (353845)

ARTG ID

353845

ARTG Name

TYSABRI natalizumab 150 mg/1 mL injection solution pre-filled syringe

Sponsor

Biogen Australia Pty Ltd

ARTG Date

December 7, 2021

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

BIOGEN AUSTRALIA PTY LTD

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2012-CMI-01052-3

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2012-PI-01015-3

Ingredient Name

Natalizumab

Empowering clinical research with data-driven insights and AI-powered tools.

TYSABRI natalizumab 150 mg/1 mL injection solution pre-filled syringe (353845) - TGA 批准文号 | MedPath